Skip to content
lifestyle.travelshq.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Telix Pharmaceuticals Limited
FDA Approves Telix’s Brain Cancer Imaging Drug Pixclara
September 14, 2026
Telix to Present at the Morgan Stanley 24th Annual Global Healthcare Conference and H.C. Wainwright 28th Annual Global Investment Conference
September 9, 2026
Telix Completes Enrollment in Phase 3 BiPASS Study, Aligns with FDA on NDA Pathway
September 1, 2026
Telix Appoints David Gill as Chair
August 31, 2026
Telix 2026 Half-Year Results: Strong Commercial Execution and Momentum in Late-Stage Pipeline
August 19, 2026
Telix to Host R&D Day in New York City on September 22, 2026
August 5, 2026
Telix H1 2026 Results: Investor Webcast Notification
July 30, 2026
IPAX-2 Study of TLX101-Tx in First-line Glioblastoma Completes Enrolment and Confirms Dosing
May 18, 2026
New Publication Demonstrates TLX250-Px (Zircaix®) Potential in Diagnosing Kidney Cancers Beyond ccRCC
May 4, 2026
TLX101-Px (Pixlumi®) MAA Accepted in Europe
April 30, 2026
1
2
3
Next Page
→